01 December 2020

The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.

The legal case was brought against the Tavistock and Portman NHS Trust which leads the national Gender Identity and Development Service (GIDS). The puberty blocking drugs provided by the service are prescribed and administered by endocrinologists at UCLH and Leeds Teaching Hospitals NHS Trust.

Our statement in response to the ruling is as follows:

A UCLH spokesperson said: “We are disappointed with the court’s decision. The Tavistock and Portman NHS Foundation Trust is seeking permission to appeal this judgement and we support this. Our priority is our patients and we will be working closely with the Tavistock to support those affected by the court’s ruling.”

Further information is available on the GIDS website: www.gids.nhs.uk

If you are a patient or parent concerned about the ruling please call 07812 512 126. This number is for patients and their families only.

Journalists should email uclh.media@nhs.net. This email address is for members of the media only. 

Return to News

Contact the team

Communications Unit
2nd floor central
250 Euston Road
London NW1 2PG

Media enquiries

Email: uclh.media@nhs.net
This inbox is monitored throughout the day and we respond to enquiries as soon as possible.

Out of hours

The normal working hours for the Communications Unit are Monday to Friday 9am – 5pm. The only media enquiries that will be answered outside of these working hours are urgent enquiries and those relating to major incidents. To access the out-of-hours service, call the switchboard on 020 3456 7890.